PrimeGen US to Combine with DT Cloud Star Acquisition Corporation at $1.5 Billion Valuation

Reuters
Feb 04
PrimeGen US to Combine with <a href="https://laohu8.com/S/DTSQU">DT Cloud Star Acquisition Corporation</a> at $1.5 Billion Valuation

PrimeGen US, Inc. and DT Cloud Star Acquisition Corporation have announced a proposed business combination at an implied equity value of approximately $1.5 billion. The transaction aims to advance PrimeGen US’s stem cell research and development efforts. Further details, including a joint investor presentation and additional documentation, are expected to be made available through filings with the U.S. Securities and Exchange Commission.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DT Cloud Star Acquisition Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9648601-en) on February 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10